CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas

APMIS

Volumn 118, Issue 4, 2010, Pages 297-307

  Alves, Markênia Kélia Santos ^a   Lima, Valeska Portela ^a   Ferrasi, Adriana Camargo ^b   Rodrigues, Maria Aparecida ^b   De Moura Campos Pardini, Maria Inês ^b   Rabenhorst, Silvia Helena Barem ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Gastric cancer; Helicobacter pylori genotypes; Histological subtypes; Methylation; P16INK4A; Tumor location

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; CAGE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; PROTEIN FLAA; PROTEIN VIRB11; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CANCER CLASSIFICATION; CANCER LOCALIZATION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME INACTIVATION; FEMALE; GASTRECTOMY; GENOTYPE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENE SILENCING; GENES, P16; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 77949879997     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02591.x     Document Type: Article

References (53)

1. Jemal ADVM, Siegel RMPH, Ward E, Murray T, Xu J, Smigal CMPH, et al. Cancer statistic, 2006. CA Cancer J Clin 2006 56 : 106 130.
2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase no. 5, version 2.0. Lyon : IARC Press, 2004.
3. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006 12 : 192 198.
4. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002 1602 : 73 87.
5. Lima VP, de Lima MA, André AR, Ferreira MV, Barros MA, Rabenhorst SH. H. pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol 2008 14 : 884 891.
6. Lima EM, Leal MF, Burbano RR, Khayat AS, Assumpção PP, Bello MJ, et al. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz J Med Biol Res 2008 41 : 539 543.
7. Ding Y, Le XP, Zhang QX, Du P. Methylation and mutation analysis of p16 gene in gastric cancer. World J Gastroenterol 2003 9 : 423 426.
8. Zhao GH, Li TC, Shi LH, Xia YB, Lu LM, Huang WB, et al. Relationship between inactivation of p16 gene and gastric carcinoma. World J Gastroenterol 2003 9 : 905 909.
9. Shim YH, Kang GH, Ro JY. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000 80 : 689 695.
10. Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clin Chim Acta 2009 404 : 128 133.
11. Kim MA, Lee HS, Yang HK, Kim WH. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer 2005 103 : 1439 1446.
12. Peek RM Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002 2 : 28 37.
13. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006 1 : 63 96.
14. Sozzi M, Tomasini ML, Vindigni C, Zanussi S, Tedeschi R, Basaglia G, et al. Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection. J Lab Clin Med 2005 146 : 262 270.
15. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999 284 : 1328 1333.
16. Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell 2005 16 : 4954 4966.
17. Wang HT, Li ZH, Yuan JP, Zhao W, Shi XD, Tong SQ, et al. Effect of Helicobacter pylori VacA on gene expression of gastric cancer cells. World J Gastroenterol 2005 11 : 109 113.
18. Krause S, Pansegrau W, Lurz R, Cruz F, Lanka E. Enzymology of type IV macromolecule secretion systems: the conjugative transfer regions of plasmids RP4 and R388 and the cag pathogenicity island of Helicobacter pylori encode structurally and functionally related nucleoside triphosphate hydrolases. J Bacteriol 2000 182 : 2761 2770.
19. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999 44 : 336 341.
20. Suerbaum S. The complex flagella of gastric Helicobacter species. Trends Microbiol 1995 3 : 168 170.
21. Chan AO, Huang C, Hui WM, Cho CH, Yuen MF, Lam SK, et al. Stability of E-cadherin methylation status in gastric mucosa associated with histology changes. Aliment Pharmacol Ther 2006 24 : 831 836.
22. Dong CX, Deng DJ, Pan KF, Zhang L, Zhang Y, Zhou J, et al. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int J Cancer 2009 124 : 434 439.
23. Tahara T, Arisawa T, Shibata T, Nakamura M, Yoshioka D, Okubo M, et al. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur J Gastroenterol Hepatol 2009 21 : 613 619.
24. Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A'rabi A, Forghani MN, et al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol 2008 14 : 2055 2060.
25. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003 52 : 502 506.
26. Foster G, Twell D. Plant Gene Isolation: Principles and Practice. Chichester, UK : John Wiley & Sons, 1996. p. 426.
27. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996 93 : 9821 9826.
28. Lage AP, Godfroid E, Fauconnier A, Burette A, Butzler JP, Bollen A, et al. Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol 1995 33 : 2752 2756.
29. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995 270 : 17771 17777.
30. Domingo D, Alarcon T, Pietro N, Sanchez I, Lopez-Brea M. cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol 1999 37 : 2113 2114.
31. Göttke MU, Fallone CA, Barkun AN, Vogt K, Loo V, Trautmann M, et al. Genetic variability determinants of Helicobacter pylori: influence of clinical background and geographic origin of isolates. J Infect Dis 2000 181 : 1674 1681.
32. Landberg G, Roos G. Proliferating cell nuclear antigen and Ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation. Cell Prolif 1993 26 : 427 437.
33. McCarty KS Jr., Miller LS, Cox EB, Konrath J, McCarty KS Sr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985 109 : 716 721.
34. Zhou J, Yang D, Zhang L, Wang J, Yao Q, Su Z, et al. Study on the relationship of alteration and expression of p16 gene to pancreatic carcinoma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2000 17 : 399 403.
35. Goto T, Mizukami H, Shirahata A, Sakata M, Saito M, Ishibashi K, et al. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2009 29 : 275 277.
36. Vidaurreta M, Maestro ML, Sanz-Casla MT, Maestro C, Rafael S, Veganzones S, et al. Inactivation of p16 by CpG hypermethylation in renal cell carcinoma. Urol Oncol 2008 26 : 239 245.
37. Napieralski R, Ott K, Kremer M, Becker K, Boulesteix AL, Lordick F, et al. Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features. Clin Cancer Res 2007 13 : 5095 5102.
38. He XS, Rong YH, Su Q, Luo Q, He DM, Li YL, et al. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance. World J Gastroenterol 2005 11 : 2218 2223.
39. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002 8 : 1153 1160.
40. Honda T, Tamura G, Endoh Y, Nishizuka S, Kawata S, Motoyama T. Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach. Jpn J Clin Oncol 2005 35 : 580 586.
41. Kishimoto I, Mitomi H, Ohkura Y, Kanazawa H, Fukui N, Watanabe M. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. J Surg Oncol 2008 98 : 60 6.
42. Mino A, Onoda N, Yashiro M, Aya M, Fujiwara I, Kubo N, et al. Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway. Oncol Rep 2006 15 : 615 620.
43. Zhao YF, Zhang YG, Tian XX, Juan Du, Zheng J. Aberrant methylation of multiple genes in gastric carcinomas. Int J Surg Pathol 2007 15 : 242 251.
44. Wu Q, Possati L, Montesi M, Gualandi F, Rimessi P, Morelli C, et al. Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the p16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9. Int J Cancer 1996 65 : 840 846.
45. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999 59 : 5438 5442.
46. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004 157 : 327 349.
47. Tahara E, Kuniyasu H, Yasui W, Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994 6 : S97 102.
48. Driessen A, Nafteux P, Lerut T, Van Raemdonck D, De Leyn P, Filez L, et al. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 2004 17 : 49 55.
49. Driessen A, Van Raemdonck D, De Leyn P, Filez L, Peeters M, Winnepenninckx V, et al. Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 2003 39 : 2487 2494.
50. Obst B, Wagner S, Sewing KF, Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 2000 21 : 1111 1115.
51. Hmadcha A, Bedoya FJ, Sobrino F, Pintado E. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med 1999 190 : 1595 1604.
52. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007 42 : 1 15.
53. Velicescu M, Weisenberger DJ, Gonzales FA, Tsai YC, Nguyen CT, Jones PA. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res 2002 62 : 2378 2384.